InvestorsHub Logo
Followers 0
Posts 127
Boards Moderated 0
Alias Born 04/21/2011

Re: antihama post# 1937

Monday, 11/13/2017 10:51:54 AM

Monday, November 13, 2017 10:51:54 AM

Post# of 3283

I would have to say 351a. Why? Well, besides that at almost every CC they indicate that Rolontis is a novel molecule, another sign is they are measuring Duration of severe neutropenia (DSN) which is an endpoint for efficacy. If they were taking the 351k route they would be measuring potency rather than efficac



If this is true then this is the nex big thing where he threw smoke and mirrors. This guy is intentionally misleading all the time. That really annoys the heck out of me!